IN8bio Inc

-0.06 (-2.78%)
Earnings Announcements

IN8bio Reports Q4 And Full-Year 2021 Financial Results

Published: 03/17/2022 20:25 GMT
IN8bio Inc (INAB) - In8bio Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.44.
As of December 31, 2021, Company Had Cash of $37.0 Million.
Net Loss of $5.9 Million, Or $0.44 per Basic and Diluted Common Share, for Three Months Ended December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.